NM_170707.4:c.16C>T
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_170707.4(LMNA):c.16C>T(p.Gln6*) variant causes a stop gained change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★).
Frequency
Consequence
NM_170707.4 stop_gained
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 12 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
LMNA | NM_170707.4 | c.16C>T | p.Gln6* | stop_gained | Exon 1 of 12 | ENST00000368300.9 | NP_733821.1 | |
LMNA | NM_005572.4 | c.16C>T | p.Gln6* | stop_gained | Exon 1 of 10 | ENST00000677389.1 | NP_005563.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Emery-Dreifuss muscular dystrophy 2, autosomal dominant Pathogenic:1Other:1
- -
- -
Primary dilated cardiomyopathy Pathogenic:1
The Gln6X variant has been reported in one large family with Emery-Dreifuss musc ular dystrophy. It segregated with disease in 17 affected members and was absent from 300 control chromosomes. Of note, the majority of individuals presented wi th cardiomyopathy only (Becane 2000, Bonne 1999). This variant leads to a prema ture stop at codon 6 and is predicted to lead to a truncated or absent protein, which is consistent with protein expression studies (Becane 2000). In summary, this variant meets our criteria for pathogenicity (http://pcpgm.partners.org/LMM ) based upon the severity of the change, segregation studies and absence from co ntrol chromosomes. -
not provided Other:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at